MedTrace Logo

The Impact of Depression and/or Anxiety on PCI Patients

NCT03057691 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2018-11-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate how depression and/or anxiety could effect the prognosis of the patients post-ACS after PCI.

Conditions

Interventions

OTHER

antidepressive and anti-anxiety therapy

These therapies include antidepressants, antianxiety drugs and psychotherapy. Subjects choose the therapy follow their own will. All of the above-mentioned therapies are identified by experienced psychiatrists in the same center. The treatment information will be recorded in each visit. The study is considered non-interventional, and no antidepressive or anti-anxiety therapies are mandated.

Sponsors & Collaborators

  • Shaanxi Provincial People's Hospital

    collaborator OTHER

  • The First Hospital of Xi An City

    collaborator UNKNOWN

  • Baoji Central Hospital

    collaborator OTHER

  • General Hospital of Ningxia Medical University

    collaborator OTHER

  • The People's Hospital of Ningxia

    collaborator OTHER

  • Wuzhong City People's Hospital

    collaborator UNKNOWN

  • LanZhou University

    collaborator OTHER

  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER

  • Xinjiang Provincial People's Hospital

    collaborator UNKNOWN

  • the First Division Hospital of Xinjiang Production and Construction Corps

    collaborator UNKNOWN

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Zuyi Yuan, Professor · First Affiliated Hospital Xi'an Jiaotong University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-11
Primary Completion
2019-12-31
Completion
2020-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03057691 on ClinicalTrials.gov